Latest in News & Research
Drop in Lymph Node Dissection Seen for Melanoma Patients With Positive SLNs
Decrease seen from 2012 to 2021 in patients with melanoma with two or more positive sentinel lymph nodes
Two HLA Class I Alleles Independently Linked to Allopurinol-Induced SCARs
HLA-B*58:01 and HLA-A*34:02 linked to increased risk, while no HLA class II alleles were identified
FDA Issues Safety Alert for Radiofrequency Microneedling
Reported complications include severe burns, scarring and nerve damage, sometimes requiring surgery
Early Change in Family Structure May Increase Risk for Psoriasis
Children experiencing the psychological stress of 'new family structure' in first year of life have increased psoriasis risk
NEWS ALERT: Tralokinumab Achieves Complete Clearance After Multiple Treatment Failures in Atopic Dermatitis
A real-world case highlights the therapeutic potential of tralokinumab in patients with difficult-to-treat AD
JAKi Treatment Not Linked to Height Differences in Pediatric Patients
No significant differences in height seen for JAKi exposure in atopic dermatitis, juvenile arthritis, and inflammatory bowel disease
AI-Assisted LC-OCT Improves Dermatologists' Diagnostic Performance for BCC
Particular benefit seen for those with less LC-OCT experience, bridging a two-year gap of expertise
Gene Expression Profile Test IDs Patients Who Can Skip SLNB in Melanoma
Of patients identified as low risk by combined clinicopathological factors and GEP test, only 7.1 percent were SLN-positive
Neutrogena Makeup Wipes Recalled Due to Possible Bacteria
The U.S. Food and Drug Administration (FDA) has issued a Class II risk level for certain Neutrogena makeup remover wipes
Trend Seen for Improved Recurrence-Free Survival With Pembrolizumab in Merkel Cell Carcinoma
Recurrence-free survival was numerically higher with adjuvant pembrolizumab, but difference was not significant
Hydrocolloid Dressing Suitable Option After Dermatologic Surgery
Scar appearance and complication rates similar to those seen with daily petroleum ointment
Ustekinumab May Be Linked to Lower Cancer Risk Than Adalimumab in Psoriasis
Five-year cancer risk 56 percent lower with ustekinumab using 24-month lag times after treatment initiation
Recurrence-Free Survival Longer With Nivolumab Than Ipilimumab in Melanoma
Median duration of recurrence-free survival was 61.1 months with nivolumab and 24.2 months with ipilimumab
Incidence of Dermatologic Disease Persists in People With HIV
Associations with higher dermatologic disease risk seen for lower nadir CD4 count, older age, public insurance
2021 to 2024 Saw Increase in Prevalence of Atopic Dermatitis
AD prevalence increased for both sexes; was most prevalent among children aged 6 to 11 years and declined with age
Skin Cancer Surveillance Program Improves Screening for Solid Organ Transplant Recipients
KP-SUNTRAC associated with improved skin cancer screening rates and detection among solid organ transplant recipients
Child’s Atopic Dermatitis Linked to Maternal Depression Scores
Association stronger among mothers from lower socioeconomic backgrounds managing severe child AD in early childhood
FDA Approves Zoryve for Atopic Dermatitis in Young Children
The once-daily cream can be used anywhere on the body and offers an alternative to steroids in children ages 2 to 5 years
A New Era for Dermatology PAs and NPs Begins with PANP360
The one-of-a-kind platform unites peer connection, clinical learning, and purpose under one home
Cash Balance Plans: A Strategic Retirement Option for High-Earning Dermatologists
Are you a high-earning dermatologist wondering if you’re truly maximizing your retirement savings? What if there was a way to potentially enhance your nest...
Cosibelimab Tied to Robust, Durable Response for Cutaneous Squamous Cell Carcinoma
Findings seen for patients with metastatic or locally advanced disease, with low rates of severe immune-related adverse events
Some Patients With Alopecia Achieve Treatment Success After Switching JAKis
Authors say conclusions cannot be drawn regarding the frequency of treatment failure or success of the JAKis
Hyaluronic Acid Fillers Restore Facial Volume, Fullness
Greatest volume maintenance seen in the midface and greatest loss around the mimetic areas
24 of 1238